TREATMENT WITH CERTOLIZUMAB PEGOL IN RA - DATA FROM THE NATIONAL REGISTRY ARTIS (ANTIRHEUMATIC THERAPIES IN SWEDEN)

被引：0
|
作者：
Chatzidionysiou, K. [1 ]
van Vollenhoven, R. [1 ]
机构：
[1] Karolinska Inst, Clintrid, Dept Rheumatol, Stockholm, Sweden
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.3084
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：517 / 518
页数：2
相关论文
共 50 条
  • [31] EARLY RESPONSE TO CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS PREDICTS OUTCOME: DATA FROM A PROSPECTIVE OBSERVATIONAL STUDY
    Saraux, A.
    Flipo, R.
    Fagnani, F.
    Massol, J.
    Combe, B.
    Huot-Marchand, P.
    Joubert, J.
    Dunkel, J.
    Cukierman, G.
    VALUE IN HEALTH, 2017, 20 (09) : A526 - A526
  • [32] EARLY RESPONSE TO CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS PREDICTS OUTCOME: DATA FROM A PROSPECTIVE OBSERVATIONAL STUDY
    Saraux, A.
    Flipo, R. M.
    Fagnani, F.
    Massol, J.
    Combe, B.
    Huot-Marchand, P.
    Joubert, J. M.
    Dunkel, J.
    Cukierman, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 786 - 787
  • [33] Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of Data From Clinical Trials
    Loftus, Edward V., Jr.
    Colombel, Jean-Frederic
    Schreiber, Stefan
    Randall, Charles W.
    Regueiro, Miguel
    Ali, Tauseef
    Arendt, Catherine
    Coarse, Jason
    Spearman, Marshall
    Kosutic, Gordana
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (12) : 1753 - 1762
  • [34] Effectiveness and survival-on-drug of certolizumab pegol in rheumatoid arthritis in clinical practice: results from the national Swedish register
    Chatzidionysiou, K.
    Kristensen, L-E
    Eriksson, J.
    Askling, J.
    van Vollenhoven, R.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2015, 44 (06) : 431 - 437
  • [35] One-year risk of serious infection in patients treated with certolizumab pegol as compared with other TNF inhibitors in a real-world setting: data from a national U.S. rheumatoid arthritis registry
    Leslie R. Harrold
    Heather J. Litman
    Katherine C. Saunders
    Kimberly J. Dandreo
    Bernice Gershenson
    Jeffrey D. Greenberg
    Robert Low
    Jeffrey Stark
    Robert Suruki
    Srihari Jaganathan
    Joel M. Kremer
    Mohamed Yassine
    Arthritis Research & Therapy, 20
  • [36] TNF-antagonist treatment and risk of hospitalisation for infection. Results from the national Swedish monitoring-programme for biologics in RA (artis)
    Askling, J.
    Fored, M.
    Brandt, L.
    Baecklund, E.
    Bertilsson, L.
    Coster, L.
    Geborek, P.
    Jacobsson, L.
    Lindblad, S.
    Lysholm, J.
    Rantapaa-Dahlqvist, S.
    Saxne, T.
    Feltelius, N.
    Klareskog, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 110 - 110
  • [37] Certolizumab pegol in patients with Crohn's disease who failed treatment with other anti-TNFs: data from a compassionate use program
    Vermeire, S.
    Collin, B.
    Mitchev, K.
    Howaldt, S.
    Hommes, D.
    Rutgeerts, P.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (01) : S29 - S29
  • [38] Number Needed to Treat to Achieve Broad Relief From the Burden of Rheumatoid Arthritis (RA) in Patients Treated With Certolizumab Pegol Plus Methotrexate
    Strand, Vibeke
    Van Vollenhoven, Ronald
    Kvien, Tore
    Combe, Bernard
    Khanna, Dinesh
    Burmester, Gerd
    Nikai, E.
    Coteur, G.
    Smolen, Josef
    Schiff, Michael
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1153 - 1153
  • [39] Registry data from Sweden Real-life data on urticaria
    Lux, Sebastian
    ALLERGO JOURNAL, 2022, 31 (05) : 8 - 8
  • [40] TNF-antagonist treatment and risk of hospitalisation for infection.: Results from the National Swedish Monitoring-Program for Biologics in RA (ARTIS).
    Askling, Johan
    Fored, M.
    Brandt, L.
    Baecklund, E.
    Bertilsson, L.
    Coster, L.
    Geborek, P.
    Jacobsson, L.
    Lindblad, S.
    Lysholm, J.
    Rantapaa-Dahlqvist, S.
    Saxne, T.
    van Vollenhoven, R.
    Feltelius, N.
    Klareskog, L.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S420 - S421
12345